UBS Group’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,224
| Closed | -$14K | – | 10188 |
|
|
2022
Q2 | $14K | Buy |
2,224
+2,174
| +4,348% | +$13.7K | ﹤0.01% | 6416 |
|
|
2022
Q1 | $0 | Sell |
50
-189
| -79% | – | ﹤0.01% | 9987 |
|
|
2021
Q4 | $1K | Sell |
239
-271
| -53% | -$1.13K | ﹤0.01% | 8994 |
|
|
2021
Q3 | $3K | Sell |
510
-453
| -47% | -$2.67K | ﹤0.01% | 7735 |
|
|
2021
Q2 | $8K | Buy |
963
+189
| +24% | +$1.57K | ﹤0.01% | 7173 |
|
|
2021
Q1 | $9K | Buy |
774
+575
| +289% | +$6.69K | ﹤0.01% | 7007 |
|
|
2020
Q4 | $1K | Sell |
199
-362
| -65% | -$1.82K | ﹤0.01% | 7255 |
|
|
2020
Q3 | $3K | Buy |
561
+436
| +349% | +$2.33K | ﹤0.01% | 6708 |
|
|
2020
Q2 | $1K | Sell |
125
-1,073
| -90% | -$8.58K | ﹤0.01% | 6980 |
|
|
2020
Q1 | $4K | Buy |
1,198
+1,073
| +858% | +$3.58K | ﹤0.01% | 6509 |
|
|
2019
Q4 | $1K | Sell |
125
-465
| -79% | -$3.72K | ﹤0.01% | 6929 |
|
|
2019
Q3 | $8K | Sell |
590
-596
| -50% | -$8.08K | ﹤0.01% | 6336 |
|
|
2019
Q2 | $17K | Buy |
1,186
+547
| +86% | +$7.84K | ﹤0.01% | 5863 |
|
|
2019
Q1 | $27K | Sell |
639
-1,377
| -68% | -$58.2K | ﹤0.01% | 5222 |
|
|
2018
Q4 | $84K | Buy |
2,016
+315
| +19% | +$13.1K | ﹤0.01% | 4802 |
|
|
2018
Q3 | $82K | Buy |
1,701
+977
| +135% | +$47.1K | ﹤0.01% | 4883 |
|
|
2018
Q2 | $34K | Buy |
724
+200
| +38% | +$9.39K | ﹤0.01% | 5389 |
|
|
2018
Q1 | $33K | Buy |
524
+124
| +31% | +$7.81K | ﹤0.01% | 5165 |
|
|
2017
Q4 | $22K | Sell |
400
-100
| -20% | -$5.5K | ﹤0.01% | 5527 |
|
|
2017
Q3 | $34K | Sell |
500
-128
| -20% | -$8.7K | ﹤0.01% | 5184 |
|
|
2017
Q2 | $34K | Buy |
628
+46
| +8% | +$2.49K | ﹤0.01% | 5010 |
|
|
2017
Q1 | $21K | Buy |
+582
| New | +$21K | ﹤0.01% | 5201 |
|
|
2016
Q3 | – | Sell |
-94
| Closed | -$4K | – | 6913 |
|
|
2016
Q2 | $4K | Buy |
+94
| New | +$4K | ﹤0.01% | 6349 |
|